
--- Page 1 ---
UUID:4F3E197A-9731-427C-A2A8-2D506A1C717B TCGA-C8-A278-01A-PR Redacted IrB ApprOVeD MultI-media Systems, Inc. Form Revised Clinical Case Report 1cs-0-3 (For Collection of Cancerous Tissue). Carcinoma infiltratirg duct, Nos 8500/3 Srfs: Lresst,Nos C50.9 L 5/7ufu Informed Consent I personally informed this patient that a specimen(s) would be collected to be used for research purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Name of Physician or Study Coordinator. Signature Date Clinical Information .WRGENERALINFORMATION Data of Birth (mm/dd/yyyy) Height Marital Status Race Temperature Single Married 37c Gender Welght  Divorced  Widow Blood Pressure Heart Rate  Male Female 42v78o mm 1] 88 0m 0 EPRA SAATSAHISTORYORPRESENTILLNESS Chief Complaints: htuiit beag# Symptoms: Dhe.t F hReaet me nmta ago thee Clinica! Findings: - the Gw podas asg euiarue. Performance Scale (Karnofsky Score):  100 Asymptomatic   80-90 Symptomatic but Fully Ambulatory   60-70 Symptomatic, in bed less than 50% of day  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden.  20-30 Bed Ridden AE  W   CURRENT MEDICATIONS  Drug Dose Route Frequency Date (mm/dd/yyyy) To N0 To To To To

--- Page 2 ---
PAST MEDICAL HISTORY Diagnosis/Disease/Disorder/Injury  Diagnosis Date Treatment Status 1 ape*** whwW.OB/GYNHISTORY .w..w.W. Menopausal Status Date of First Menses # of Pregnancies  Pre-menopausal yeas-e!  Peri-Menopausal Date of Last Menses # of Live Births Post-menopausal yeasrlel Birth Control:  Condom  Oral Contractpuve  IUD  Hormone Replacement  Other: Therapy: w.pSOCIAL.HISTORYei Occupation: Environmental Hazards: Smoking History Current Status TypE  Packs/day Duration When Quit yES ANO (yrs) (yt). Alcohol Consumption Current Status TYPE Drlnks/day Duratlon When Quit  yes no (yrs) (yr) Drug Use Current Status TyPE Freguency. Duration When Quit  yES ANO (yrs) 1 (vr ETMS FAMILYMEDICALHISTORYM  *ESN Relative Dlagnosis Age of Diagnosis AARALABDATAA Test Result  Date Test Result Date HIV Negative  Positive: CEA  Negative  Positive: Hep B Negative  Positive: CA 15-3  Negative  Positive: Hep C CA 19-9   Negative  Positive:   Negative  Positive: AFP  Negative  Positive: PSA   Negative  Positive: Other: Other:  Negative  Positive:  Negative  Positive: B/T Cell Markers:

--- Page 3 ---
DIAGNOSTIC STUDIES Study  Results Date Ultrasound X-Ray   CT Endoscopy MRI Biopsy BL WAM MCLINICALDIAGNOSIS  N  Preoperative Clinical Diagnosis Deast Cauer Location of Suspected Involved Lymph Nodes. Location of Suspected Distant Metastasis. Axlla NO Clinical Staging Date of Diagnosis Tg N1 Mo Stage: PR Treatment Information AAMASURGICALTREATMENTRC Procedure Date of Procedure Ya teu's hrm Primary Tumor Organ Detalled Location Size Rgeat Loxrs Ga ls 19.5x V x cm Extenslon of Tumor ND Lymph Nodes Description Location of Lymph Nodes # of Lymph Nodes Palpable, Non-Dissected Lymph Nodes 6 Dissected Lymph Nodes Distant Metastasis  Organ Detalled Location Size Surgical Staging A T9 No. M o Stage:  NEOADJUVENTTHERAPY (Chemo, Radiation, Immuno, Hormonal, or Molecular). .. . Drug/Treatment Dose Route Frequency Date (mm/dd/yyy) To NO To / To To To

--- Page 4 ---
Pathology Form Specimen Information Date: Time: Collected by: Preserved by: Date:  .me: MSPECIMEN TYPE #Of.samples provided  Paraffin Block Biooa/Serum/Plasma Slide Frozen Normal Diseased-  Normal Diseased Normal Diseased  Normal Diseased Time to Formalin. Time to LN2 Time to LN2 min 60 min g No min BMPATHOLOGICALDESCRIPTIONAAAAS Primary Tumor Size Extension of Tumor Distance to NAT Organ Raeat 9.5x cm cm Lymph Nodes # Examinedd # Metastasized Location Axill. 6. 6 Distant Metastasis  Size Organ Detailed Location NU Pathologica! Staging Ny M o Stage: WLA pT 9 Notes:

--- Page 5 ---
CONsoLIDated DIagNostIc pathoLOgy foRm* Microscopic Appearance: Histological pattern: CELL DISTRIBUTION Diffuse STRUCTURAL PATTERN Mosaic X Streamin Necrosis X  Storiform Lymphocytic infiltration x Fibrosis Vascular Invasion X Palisading Clusterized XCystic Degeneration Alveolar Formation X Bleeding Indian File Myxoid Change 2. Cellular features:  Psammoma/Calcification Souamous + Adenomatous Sguamoid Cell + Sarcomatous Glandular cell Lymphomatous Splnd!e Cell X Round Cel! Cell Stratification Larre Cell Keratin M Fibroblast Small Cell Secretion Desmosome Osteoblast RS CeIl/RS Like Intracyt. Vacuole Lipoblast Pear! Inflam. Cell Giand formation Myoblast Plasma Cell Otherwise Specified: D7O7 bz7oZ Meesrs 2. Cellular Differentiation: Well Moderaely Poor Nuclear Atypia: Nuckar Appearance 11 Aniso Nucleosis Hyperchromatism Nucleolar Prominent Multinucleated Giant Cel! 9 Mitotic Activity Nuckear Grade Histological Diagnosis: iofilt&g /ny Dsetal Caecrm, Ats., G2 M, M2 caAtrmg rla? tgsBed to 2N Comments: Date Director, Research Pattoiogy PATHOLOGIST STAFF FOR RESEARCH USE ONLY). *(INTEGRATED REPORT OF FINDINGS BY CONTRISUTOR ANO .